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Abstract
Background: Lentinula edodes, known as shiitake, has been utilized as food, as well as, in popular medicine,
moreover, compounds isolated from its mycelium and fruiting body have shown several therapeutic properties.
The aim of this study was to determine the antiviral activity of aqueous (AqE) and ethanol (EtOHE) extracts and
polysaccharide (LeP) from Lentinula edodes in the replication of poliovirus type 1 (PV-1) and bovine herpes virus
type 1 (BoHV-1).
Methods: The time-of-addition assay was performed at the times -2, -1, 0, 1 and 2 h of the infection. The virucidal
activity and the inhibition of viral adsorption were also evaluated. Plaque assay was used to monitor antiviral
activity throughout.
Results: The AqE and LeP were more effective when added at 0 h of infection, however, EtOHE was more
effective at the times 1 h and 2 h of the infection. AqE, EtOHE and LeP showed low virucidal activity, and the
inhibition of viral adsorption was not significant.
Conclusions: The results allowed us to conclude that AqE, EtOHE and LeP act on the initial processes of the
replication of both strains of virus.
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Background
Currently, there are a little more than 40 drugs
approved for clinical use in the treatment of viral infec-
tions [1]. Studies regarding these drugs concentrated on
synthetic products up to the end of the 80 s, when nat-
ural compounds attracted attention because of their effi-
cacy in the inhibition of viruses important for human
and animal health [2]. Natural products are recognized
by the pharmaceutical industry because of their wide
structural diversity, as well as, variety of pharmacological
activities [3]. Amongst the sources of natural com-
pounds, the fungi, especially the basidiomycetes, have
stimulated interest from investigators.
The basidiomycete Lentinula edodes (Berkeley) Pegler
(Lentinus edodes), known as shiitake, an edible mush-
room native of the East Asia, is valued for its nutritional
and medicinal properties and culinary and industrial
applications [4]. Shiitake is the second most popular in
the world [5] and in the last decades various compounds
with therapeutic properties have been isolated from its
mycelium and fruiting body. Some of these have been
widely studied, for example, the polysaccharide lentinan
which has demonstrated high immunopotentiating and
antimetastasic activities [6,7], antitumor activity [8,9],
antibacterial, antifungal and antidiabetic activities
[10,11], among others. However, few works have exam-
ined the antiviral activity of this basidiomycete [12-14].
Poliovirus is a non-enveloped virus with an icosahe-
dral capsid symmetry, and a genome consisting of a
positive single-stranded RNA. The virion is classified in
the genus Enterovirus, belonging to the family Picorna-
viridae, which includes many other pathogens of great
importance to humans and other animals [15]. Despite
the efforts to eradicate the virus, there were 1352
reported cases of poliomyelitis in African and Asian
countries in 2010 [16]. Bovine herpesvirus (BoHV) is an
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belongs to the subfamily Alphaherpesvirinae, family Her-
pesviridae [17], has a genome consisting of a linear dou-
ble-stranded DNA within an icosahedral capsid,
enclosed by an envelope. In order to reduce losses
caused by BoHV, vaccines consisting of attenuated virus
are being utilized with positive results. However, the
control of infections is still difficult, due to the latency
established by the virus after primary infection or after
vaccination [18].
The basidiomycetes show various biological activities
and low toxicity what make them a promising source of
bioactive molecules. Therefore, the aim of this study
was to determine the antiviral activity of aqueous and
ethanol extracts and polysaccharide of Lentinula edodes
in the replication of poliovirus and bovine herpesvirus.
Methods
Cells and virus
HEp-2 cell cultures (human larynx epithelial cells carci-
noma–ATCC, CCL-23) were grown in Dulbecco’s Mod-
ified Eagle Medium (DMEM) (Gibco-BRL, EUA*),
supplemented with 10% fetal bovine serum (*) and 2
mM glutamine (Sigma Chem. Co., EUA**), 100 μg/ml
streptomycin (**), 100 IU/ml penicillin (**) and 2.5 μg/
ml amphotericin B (Bristol Myers-Squibb, Brazil).
The poliovirus type 1 (PV-1), vaccinal strain, was
obtained from the ATCC (ATCC, VR-58) and the
bovine herpesvirus type 1 (BoHV-1) was supplied by
DMVP-UEL, Brazil. Both strains were propagated in
HEp-2 cells, and virus titers determined by plaque assay.
Aqueous and ethanol extracts
The aqueous extract (AqE) of Lentinula edodes (lineage
IW) was obtained as follows. Ground basideocarp was
resuspended with distilled water, heated at 60°C for 1 h
and centrifuged at 3000 × g for 5 min. The supernatant
was pre-filtered and submitted to ultrafiltration in 0.2
μm pore size membrane, and stored at -20°C.
The ethanol extract (EtOHE) was prepared by dissol-
ving ground basideocarp in 46% ethanol, at room tem-
perature (± 25°C). The extract was centrifuged at 3,000
× g for 5 min, and the supernatant was lyophilized. The
lyophilized was resuspended in DMEM, submitted to
ultrafiltration in 0.2 μm pore size membrane, and stored
at -20°C.
Polysaccharide extraction and purification
The polysaccharide from Lentinula edodes (LeP) was iso-
lated as described by Gonzaga et al. [19]. Briefly, dried
mushroom was dissolved at 5% (w/w) in distilled water at
100°C during 5 h. The suspension was centrifuged and
clear colorless extract was neutralized to pH 7.0 with 0.1
N NaOH. One percent NaCl was added and the extract
submitted to polysaccharides precipitation with ethanol
(5 vol ethanol:1 vol extract). After hydrogen peroxide/
ethanol treatment, precipitate was resubmitted to ethanol
extraction. The precipitate washed with ethanol and acet-
one was dried at 40°C, dissolved in distilled water, clari-
fied by centrifugation and lyophilized.
Cytotoxic assay
The cytotoxicity of the test substances was performed by
dimethylthiazolyldiphenyl tetrazolium bromide (MTT)
kit (**). HEp-2 cells were grown in 96-well microplates
and treated with varying concentrations of AqE (0.1-100
mg/ml), EtOHE (0.1-40 mg/ml) and LeP (0.25-6.0 mg/
ml). After 72 h incubation, the test was carried out
according to the manufacturer’s recommendation.
Under the same conditions, cells without treatment
were used as control. The 50% cytotoxic concentration
(CC50) was determined as the concentration capable of
reducing the optical density by 50% in comparison with
the control. The CC50 was calculated by linear regres-
sion analysis of the dose-response curves generated.
Plaque reduction assay
The antiviral activity by plaque reduction assay was done
according to Melo et al. [20] and used throughout.
Briefly, HEp-2 cells were cultivated in 24-well plates at
37°C in 5% of CO2. After complete confluence, the cells
were infected and treated with the substances accord-
ingly. Cell cultures were overlaid with nutrient agarose
and supplemented with antibiotic. For PV-1 experiments,
nutrient agarose was added of 25 mM MgCl2. The plates
were incubated inverted at 37°C in 5% CO2, for 48 h. The
cells were fixed with 20% formalin, stained with 0.5%
crystal violet, after removal of the nutrient agarose layer.
Concomitantly, mock-infected cells were used as control.
The percentage of viral inhibition (% V.I.) was calculated
by the formula: % V.I. = [1 - (number of plaques in test/
number of plaques in virus control)] × 100.
The 50% inhibitory concentration (IC50)w a sd e t e r -
mined as the concentration capable of reducing 50% the
number of plaques forming units (PFU) in relation to
t h ec o n t r o l s .T h eI C 50 was determined by linear regres-
sion analysis of the curves of viral inhibition, for each
treatment.
The selectivity index (SI) was calculated as the ratio of
CC50 and IC50.
S t r a i n so fP V - 1a n dB o H V - 1w e r es u b m i t t e dt ot h e
treatment with 1,000 U/ml and 10,000 U/ml human
alfa-2 interferon (Meizler Com. Intern. SA, Brazil),
respectively.
Virucidal activity
To evaluate the direct effect of the substances on viral
particles, at varying concentrations, 10
6 PFU/ml of PV-1
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5 PFU/ml of BoHV-1 were mixed with equal
volumes of AqE (3.1, 6.3, 12.5 and 25 mg/ml), EtOHE
(0.375, 0.75, 1.5 and 3 mg/ml) and LeP (0.025, 0.05, 0.1
and 0.2 mg/ml) for 1 h at 37°C and inoculated in cell
cultures.
Time-of-addition assay
The evaluation of the time-of-addition effect of the sub-
stances, at varying concentrations, was done as in Yang
et al. [21]. Cells cultivated in 24-well plates were treated
with concentrations of AqE (3.1, 6.3, 12.5 and 25 mg/
ml), EtOHE (0.375, 0.75, 1.5 and 3 mg/ml) and LeP
(0.025, 0.05, 0.1 and 0.2 mg/ml), before (-1 h and -2 h),
during (0 h) and after (1 h and 2 h) infection.
Viral adsorption assay
The inhibition of the viral adsorption was carried out
according to Zhu et al. [22]. Briefly, the cells cultivated
in 24-well plates were infected with viral strains in the
presence of the AqE (3.1, 6.3, 12.5 and 25 mg/ml),
EtOHE (0.375, 0.75, 1.5 and 3 mg/ml) and LeP (0.025,
0.05, 0.1 and 0.2 mg/ml), and incubated at 4°C in 5%
CO2 for one h. The cells were washed twice with PBS,
and plaque reduction assay was performed after 48 h.
Statistics
T h ed a t aw e r ea n a l y z e db yA N O V Af o l l o w e db yS t u -
dent’s t-test. Values were considered significant to p ≤
0.05. All experiments were performed in triplicate.
Results
The polysaccharide isolated from Lentinula edodes con-
tains high levels of b-D-glucan. The
13C NMR spectrum
is shown in Figure 1 and b(1®6) and a(1®4) glucans
configurations were identified in the spectrum. The che-
mical displacements characteristics of the carbons C1 to
C6 of the glycosidic ring are presented in Table 1.
The cytotoxicity of the substances tested resulted in
CC50 for the AqE, EtOHE and LeP of 74.0 mg/ml, 25.8
mg/ml and 4.0 mg/ml, respectively (Table 2).
The results of antiviral activity for the AqE at different
times of infection for PV-1 are shown in Figure 2a. When
the AqE was added, one or two hours before infection (-1
h and -2 h), at the highest concentration tested (25 mg/
ml), there was an inhibition of 5.8% and zero%, respec-
tively. The addition of the extract at the concentrations
of 3.1, 6.3, 12.5 and 25 mg/ml, at the moment of infec-
tion (0 h), resulted in a viral inhibition of 1.8, 17.5, 41.1
and 82.5%, respectively. However, for the time-of-addi-
tion of one hour post-infection (1 h), at the same concen-
trations, the percentages of inhibition were 9.2, 12.1, 24.5
and 60.2%, respectively. With the time-of-addition of two
hours post-infection (2 h), the concentrations of 3.1 mg/
ml and 6.3 mg/ml were not effective, but, the concentra-
tions of 12.5 mg/ml and 25 mg/ml inhibited the replica-
tion of PV-1 by 28.2 and 49.4%, respectively.
The results of the tests for virucidal activity and the
inhibition of adsorption showed that the AqE inhibited
the replication of PV-1 by 38.3% and 19.0%, respectively,
at the highest concentration tested. Figure 2b shows the
results of the antiviral activity of AqE in the replication
of BoHV-1. When the cells were treated with a concen-
tration of 12.5 mg/ml, the highest percentage of viral
inhibition obtained was 19.1 and 4.2%, for the times -1
h and -2 h before the infection, respectively. At the time
0 h, for the concentrations of 3.1, 6.3, 12.5 and 25 mg/
ml there was inhibition of 50.4, 43.3, 66.7 and 89.9%,
respectively. However, for post-infection treatments, at
the same concentrations, there was inhibition of 20.4,
Figure 1
13C NMR spectrum from polysaccharide isolated from
Lentinula edodes.
Table 1 Chemical displacements characteristics of b(1®6)
and a(1®4) glucans present in the purified
polysaccharides isolated from Lentinula edodes
Configurations Chemical displacements (ppm)
C1 C2 C3 C4 C5 C6
b(1®6) 103.5 73.7 75.6 70.4 75.6 69.7
a(1®4) 99.9 72.4 76.4 81.3 71.1 61.6
Table 2 Antiviral activity of aqueous extract (AqE),
ethanol extract (EtOHE) and polysaccharide (LeP) of
Lentinula edodes for poliovirus and bovine herpesvirus,
monitored by plaque assay
Substances CC50
a PV-1 BHV-1
IC50
b SI
c IC50 SI
AqE 74.0 12.7 5.82 8.2 9.02
EtOHE 25.8 1.30 19.85 2.13 12.11
LeP > 4.0 0.19 > 21.33 0.1 > 39.21
a Fifty percent cytotoxic concentration (mg/ml)
b Fifty percent inhibitory concentration (mg/ml)
c Selectivity index
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51.5 and 75.7% for the time 2 h.
For virucidal and inhibition of adsorption activities,
there was a low inhibitory effect for the replication of
BoHV-1 (32.1% and zero%, respectively) at the highest
concentration of AqE.
T h er e s u l t so ft h eE t O H Eo nthe replication of PV-1
and BoHV-1 are shown in Figure 3. For PV-1, at con-
centrations of 0.375, 0.75, 1.5 and 3 mg/ml, the extract
inhibited replication of the virus by zero, 45.7, 56.5 and
73.9%, respectively, at time 0 h of infection (Figure 3a).
When the extract was added at the times 1 h and 2 h,
at the indicated concentrations, the percentages of inhi-
bition were 21.4, 24.8, 53.9 and 76.9%, and 20.7, 36.3,
70.8 and 94.6%, respectively. However, treatments at
times -1 h and -2 h, showed no significant effect, with
the highest inhibition of 21.7%. In the replication of
BoHV-1 (Figure 3b), at the same concentrations, the
extract showed inhibition of zero, 10.2, 32.4 and 70.8%,
respectively, for the time 0 h. Treatments at times 1 h
and 2 h resulted in inhibition of 35.4, 46.9, 56.3 and
90.6%, and, zero, 8.1, 22.3 and 47.6%, respectively. The
extract did not show any virucidal activity or inhibition
of viral adsorption either for both virus strains.
The antiviral activity of LeP on the replication of PV-1
and BoHV-1 are shown in Figure 4. For PV-1, at the
concentrations of 0.025, 0.05, 0.1 and 0.2 mg/ml, LeP
inhibited viral replication by 11.2, 21.0, 23.6 and 63.8%,
respectively, at time 0 h of infection (Figure 4a). When
the polysaccharide was added at time 1 h, at the same
concentrations, the percentages of inhibition were zero,
4.2, 2.0 and 28.5%, respectively. However, for the treat-
ments at the times 2 h, -1 h and -2 h, no effect was
observed. In the replication of BoHV-1, at the same
concentrations, LeP showed inhibition of 23.1, 29.6, 37.1
and 74.2%, respectively, for the time 0 h (Figure 4b).
Treatments at the times 1 h and 2 h showed inhibition
of 13.1, 17.9, 29.4 and 33.5%, and, zero, zero, 40.9 and
52.7%, respectively.
The LeP virucidal activity on the PV-1 replication, at
the same concentrations, showed inhibition of 14.5,
24.4, 28.5 and 34.3%. However, LeP neither demon-
strated virucidal activity for BoHV-1 nor inhibition of
viral adsorption for both virus strains.
The IC50 and the respective SI for AqE, EtOHE and
LeP, calculated for treatment at time 0 h of the infec-
tion, are shown in Table 2.
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Figure 2 Effect of Lentinula edodes aqueous extract (AqE) on
poliovirus (a) and bovine herpesvirus (b) replication,
monitored by plaque reduction assay in HEp-2 cells. The extract
was utilized in the indicated concentrations before (-1 and -2),
during (0) and after infection (1 and 2). The experiments were
carried out in triplicate, and the percent of the inhibition is
represented with the respective standard deviations.
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Figure 3 Effect of Lentinula edodes ethanol extract (EtOHE) on
poliovirus (a) and bovine herpesvirus (b) replication,
monitored by plaque reduction assay in HEp-2 cells. The extract
was utilized in the indicated concentrations before (-1 and -2),
during (0) and after infection (1 and 2). The experiments were
carried out in triplicate, and the percent of the inhibition is
represented with the respective standard deviations.
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the replication of PV-1 and BoHV-1 by 100% at concen-
trations of 1,000 U/ml and 10,000 U/ml, respectively.
Discussion
In this work, the aqueous and ethanol extracts, and,
polysaccharides of the fruiting body of Lentinula edodes
were evaluated for antiviral activity.
The results demonstrated that both extracts, as well
as, LeP, inhibited the replication of PV-1 and BoHV-1.
AqE inhibited PV-1 and BoHV-1 in a dose-dependent
curve and the highest percentages of inhibition were
obtained at time 0 h of infection. No significant inhibi-
tory effect was observed when the extract was added at
-1 h and -2 h of the infection and for the inhibition of
adsorption, for both virus. This may suggest that AqE
did not influence significantly the specific binding of
both virus to cell receptors. AqE did not show virucidal
activity, and therefore, did not affect virus particle
directly either. Sorimachi et al. [23] demonstrated that
fractions of the aqueous extract of Agaricus blazei
mycelium inhibited significantly the CPE of western
equine encephalitis (WEE) virus, herpes simplex virus
and poliovirus in Vero cells. This effect was observed
after infection demonstrating that extract of basidiomy-
cetes may contain inhibitory compounds for the initial
phases of replication at least for herpesvirus and entero-
virus. This finding strengthens the activity that we
demonstrated of AqE on PV-1 and BoHV-1 replication.
EtOHE was effective in inhibiting the replication of
both viruses. The greatest percent of viral inhibition was
demonstrated when the extract was added post-infec-
tion, 94.6% (2 h) and 90.6% (1 h) for PV-1 and BoHV-1,
respectively. It is likely, therefore, that EtOHE acted on
the initial steps of the replication, considering that AqE
did not show virucidal activity or inhibition of viral
adsorption either. Awadh Ali et al. [24] demonstrated
the presence of antiviral activity in ethanol extracts of
the fruiting body and mycelium of Inonotus hispidus
against influenza virus A and B, attributing the effect to
phenolic compounds. Concerning the relevance of glu-
can in biological activities it was demonstrated that LeP
contains higher levels of b-D-glucan in comparison with
an Agaricus blazei isolate [19]. In our study, the pro-
nounced peak representative of anomeric carbon in b
(1®6) configuration is evidence of greater concentration
of glucan in relation to that of the a configuration.
Many studies disclose b(1®3) configuration for the iso-
lated glucan from Lentinus edodes [25,26], therefore,
being different to the one disclosed in this study. Cer-
tainly, the characteristics of the cultivation region, such
as climate and growth conditions, justify such behaviour.
LeP, a b-glucan-protein with a predominance of b-1-6,
also showed a dose-dependent inhibitory effect on
BoHV-1 and PV-1, although less pronounced, neverthe-
less, with a higher SI and lower IC50, compared to AqE
and EtOHE extracts. The antiviral activity of extracts
isolated from the basidiomycetes seems to be mostly
attributed to the presence of polysaccharides. The anio-
nic feature of the molecules can interfere with early
stages of viral replication [27,28] and sulfated polysac-
charides demonstrate higher antiviral activity on envel-
oped virus [29].
Conclusions
In conclusion, we suggest that AqE, EtOHE and LeP act
on the initial processes of PV-1 and BoHV-1 replication.
The extracts and the polysaccharide could be considered
as a source of potential antiviral substances. However,
further study is necessary to better understanding of the
step(s) of viral replication where inhibition occurs.
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Figure 4 Effect of Lentinula edodes polysaccharide (LeP) on
poliovirus (a) and bovine herpesvirus (b) replication,
monitored by plaque reduction assay in HEp-2 cells. The extract
was utilized in the indicated concentrations before (-1 and -2),
during (0) and after infection (1 and 2). The experiments were
carried out in triplicate, and the percent of the inhibition is
represented with the respective standard deviations.
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